Clinical trial
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
NCT00000620 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00000620 |
|---|---|
| Title | Action to Control Cardiovascular Risk in Diabetes (ACCORD) |
| Official title | Action to Control Cardiovascular Risk in Diabetes (ACCORD) |
| Acronym | ACCORD |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH National Institute on Aging (NIA) National Eye Institute (NEI) Centers for Disease Control and Prevention U.S. Fed |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atherosclerosis, Cardiovascular Diseases, Hypercholesterolemia, Hypertension, Diabetes Mellitus, Type 2, Coronary Disease |
| Intervention type | Drug |
| Interventions | Anti-hyperglycemic Agents, Anti-hypertensive Agents, Blinded fenofibrate or placebo plus simvastatin |
| Enrollment | 10,251 |
| Start date | Sep 1, 1999 |
| Primary completion | Jun 1, 2009 |
| Completion | Dec 1, 2012 |
| First posted | Oct 28, 1999 |
| Last update posted | Nov 22, 2016 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: